- Home
- VUZI vs SRZN Comparison
VUZI vs SRZN Comparison
Compare VUZI & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VUZI | SRZN |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.0M | 213.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | VUZI | SRZN |
|---|---|---|
| Price | $2.55 | $24.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.1M | 155.5K |
| Earning Date | 03-12-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,310,001.00 | $3,604,000.00 |
| Revenue This Year | $5.53 | N/A |
| Revenue Next Year | $110.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.47 | $5.90 |
| 52 Week High | $4.82 | $25.85 |
Technical Indicators
Market Signals| Indicator | VUZI | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 60.50 |
| Support Level | $2.46 | $21.07 |
| Resistance Level | $2.75 | $25.85 |
| Average True Range (ATR) | 0.18 | 2.33 |
| MACD | -0.00 | 0.26 |
| Stochastic Oscillator | 39.26 | 78.45 |
Price Performance
Historical ComparisonAbout VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).